JW Pharmaceutical Corporation (KRX:001060)

JW Pharmaceutical Revenue

JW Pharmaceutical had revenue of 199.88B KRW in the quarter ending March 31, 2026, with 7.91% growth. This brings the company's revenue in the last twelve months to 789.95B, up 9.11% year-over-year. In the year 2025, JW Pharmaceutical had annual revenue of 775.30B with 7.77% growth.

• Revenue (ttm): 789.95B
• Revenue Growth: +9.11%
• P/S Ratio: 0.76
• Revenue / Employee: 739.65M
• Employees: 1,068
• Market Cap: 601.33B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	775.30B	55.92B	7.77%
Dec 31, 2024	719.38B	-29.15B	-3.89%
Dec 31, 2023	748.53B	64.18B	9.38%
Dec 31, 2022	684.35B	77.77B	12.82%
Dec 31, 2021	606.58B	59.25B	10.83%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 8, 2026

Data Sources Report a data error